Manulife (Manufacturers Life Insurance)
OMGA

Manulife (Manufacturers Life Insurance)’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,530
Closed -$38.4K – 3059
2024
Q1 		$38.4K Buy
+10,530
New +$40.4K ﹤0.01% 2905
2023
Q3 		– Sell
-11,027
Closed -$61.8K – 3019
2023
Q2 		$61.8K Buy
+11,027
New +$86.3K ﹤0.01% 2941

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s OMGA Position: Q2 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q2 2024, closing a stake of 10,530 shares — an estimated $38.4K sold.

Manulife (Manufacturers Life Insurance) first reported a position in OMGA in Q2 2023 and held it in 2 quarters. The position peaked at $61.8K in Q2 2023. 68 funds tracked by Wall St. Rank hold OMGA as of Q2 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 10,530 Omega Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $38.4K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Omega Therapeutics, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Manulife (Manufacturers Life Insurance)'s Omega Therapeutics, Inc. Common Stock position peaked at $61.8K in Q2 2023.
  • 68 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2024, filed 14 Aug 2024.